Ail D, Ren D, Brazhnikova E, Nouvel-Jaillard C, Bertin S, Mirashrafi SB, Fisson S, Dalkara D (2022) Systemic and local immune responses to intraocular AAV vector administration in non-human primates. Mol Ther Methods Clin Dev 24:306–316. https://doi.org/10.1016/j.omtm.2022.01.011

Article  CAS  PubMed  PubMed Central  Google Scholar 

Aljabali AAA, El-Tanani M, Tambuwala MM (2024) Principles of CRISPR-Cas9 technology: advancements in genome editing and emerging trends in drug delivery. J Drug Deliv Sci Technol 92:105338. https://doi.org/10.1016/j.jddst.2024.105338

Article  CAS  Google Scholar 

Arjomandnejad M, Dasgupta I, Flotte TR, Keeler AM (2023) Immunogenicity of recombinant Adeno-Associated Virus (AAV) vectors for Gene Transfer. BioDrugs 37:311–329. https://doi.org/10.1007/s40259-023-00585-7

Article  CAS  PubMed  PubMed Central  Google Scholar 

Aromataris E (2024) JBI Manual for evidence synthesis. https://doi.org/10.46658/JBIMES-24-01. https://synthesismanual.jbi.global

Ayala A, Cheetham J, Durham T, Maguire M (2023) The importance of natural history studies in inherited retinal diseases. Cold Spring Harb Perspect Med 13:a041297. https://doi.org/10.1101/cshperspect.a041297

Article  PubMed  Google Scholar 

Bordet T, Behar-Cohen F (2019) Ocular gene therapies in clinical practice: viral vectors and nonviral alternatives. Drug Discovery Today 24:1685–1693. https://doi.org/10.1016/j.drudis.2019.05.038

Article  CAS  PubMed  Google Scholar 

Bouzidi A, Charoute H, Charif M, Amalou G, Kandil M, Barakat A, Lenaers G (2022) Clinical and genetic spectrums of 413 north African families with inherited retinal dystrophies and optic neuropathies. Orphanet J Rare Dis 17:197. https://doi.org/10.1186/s13023-022-02340-7

Article  PubMed  PubMed Central  Google Scholar 

Boye SE, Durham T, Laster A, Gelfman CM, Sahel J-A (2023) Identifying and overcoming challenges in developing effective treatments for Usher 1B: a Workshop Report. Transl Vis Sci Technol 12:2. https://doi.org/10.1167/tvst.12.2.2

Article  PubMed  PubMed Central  Google Scholar 

Britten-Jones AC, Schultz J, Mack HG, Kearns LS, Huq AJ, Ruddle JB, Mackey DA, Hewitt AW, Edwards TL, Ayton LN (2024) Patient experiences and perceived value of genetic testing in inherited retinal diseases: a cross-sectional survey. Sci Rep 14:5403. https://doi.org/10.1038/s41598-024-56121-2

Article  CAS  PubMed  PubMed Central  Google Scholar 

Calabro KR, Boye SL, Choudhury S, Fajardo D, Peterson JJ, Li W, Crosson SM, Kim M-J, Ding D, Salvi R, Someya S, Boye SE (2019) A Novel Mouse Model of MYO7A USH1B reveals auditory and visual system haploinsufficiencies. Front Neurosci 13:1255. https://doi.org/10.3389/fnins.2019.01255

Article  PubMed  PubMed Central  Google Scholar 

Chen T-H (2020) New and developing therapies in spinal muscular atrophy: from genotype to phenotype to treatment and where do we stand? Int J Mol Sci 21:3297. https://doi.org/10.3390/ijms21093297

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen J, Guo Z, Tian H, Chen X (2016) Production and clinical development of nanoparticles for gene delivery. Mol Ther Methods Clin Dev 3:16023. https://doi.org/10.1038/mtm.2016.23

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chhaya V, Khambholja K (2021) Using Managed Entry Agreements as an Effective Tool to Handle the Uncertainty in Health Technology Assessments. Health Technology Assessment in Action. https://doi.org/10.18502/htaa.v5i4.10164

Colella P, Trapani I, Cesi G, Sommella A, Manfredi A, Puppo A, Iodice C, Rossi S, Simonelli F, Giunti M, Bacci ML, Auricchio A (2014) Efficient gene delivery to the cone-enriched pig retina by dual AAV vectors. Gene Ther 21:450–456. https://doi.org/10.1038/gt.2014.8

Article  CAS  PubMed  Google Scholar 

Cuzzuol BR, Apolonio JS, Júnior RT, da Carvalho S, de Santos LS, de Malheiro LK, Luz LH, Calmon MS, Crivellaro MS, de Lemos H, de Melo FFB (2024) Usher syndrome: genetic diagnosis and current therapeutic approaches. World J Otorhinolaryngol 11:1–17. https://doi.org/10.5319/wjo.v11.i1.1

Article  Google Scholar 

de Joya EM, Colbert BM, Tang P-C, Lam BL, Yang J, Blanton SH, Dykxhoorn DM, Liu X (2021) Usher Syndrome in the inner ear: etiologies and advances in Gene Therapy. Int J Mol Sci 22:3910. https://doi.org/10.3390/ijms22083910

Article  PubMed  PubMed Central  Google Scholar 

Dinculescu A, Stupay RM, Deng W-T, Dyka FM, Min S-H, Boye SL, Chiodo VA, Abrahan CE, Zhu P, Li Q, Strettoi E, Novelli E, Nagel-Wolfrum K, Wolfrum U, Smith WC, Hauswirth WW (2016) AAV-Mediated Clarin-1 expression in the mouse retina: implications for USH3A gene therapy. PLoS ONE 11:e0148874. https://doi.org/10.1371/journal.pone.0148874

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dinculescu A, Link BA, Saperstein DA (2021) Retinal gene therapy for Usher Syndrome: current developments, challenges, and perspectives. Int Ophthalmol Clin 61:109–124. https://doi.org/10.1097/IIO.0000000000000378

Article  PubMed  PubMed Central  Google Scholar 

Dulon D, Papal S, Patni P, Cortese M, Vincent PFY, Tertrais M, Emptoz A, Tlili A, Bouleau Y, Michel V, Delmaghani S, Aghaie A, Pepermans E, Alegria-Prevot O, Akil O, Lustig L, Avan P, Safieddine S, Petit C (2018) El-Amraoui a Clarin-1 gene transfer rescues auditory synaptopathy in model of Usher syndrome. J Clin Invest 128:3382–3401. https://doi.org/10.1172/JCI94351

Ehlers JP, Zahid R, Kaiser PK, Heier JS, Brown DM, Meng X, Reese J, Le TK, Lunasco L, Hu M, Srivastava SK (2021) Longitudinal Assessment of Ellipsoid Zone Integrity, Subretinal Hyperreflective Material, and Subretinal Pigment Epithelium Disease in Neovascular Age-Related Macular Degeneration. Ophthalmol Retina 5:1204–1213. https://doi.org/10.1016/j.oret.2021.02.012

Article  PubMed  PubMed Central  Google Scholar 

EMA (2010) EU/3/10/727 - orphan designation for treatment of retinitis pigmentosa in Usher syndrome 1B| European Medicines Agency (EMA). https://www.ema.europa.eu/en/medicines/human/orphan-designations/eu-3-10-727. Accessed 10 Sep 2024

Ferla R, Dell’Aquila F, Doria M, Ferraiuolo M, Noto A, Grazioli F, Ammendola V, Testa F, Melillo P, Iodice C, Risca G, Tedesco N, le Brun PR, Surace EM, Simonelli F, Galimberti S, Valsecchi MG, Marteau J-B, Veron P, Colloca S, Auricchio A (2023) Efficacy, pharmacokinetics, and safety in the mouse and primate retina of dual AAV vectors for Usher syndrome type 1B. Mol Therapy Methods Clin Dev 28:396–411. https://doi.org/10.1016/j.omtm.2023.02.002

Article  CAS  Google Scholar 

Finkel RS, Mercuri E, Darras BT, Connolly AM, Kuntz NL, Kirschner J, Chiriboga CA, Saito K, Servais L, Tizzano E, Topaloglu H, Tulinius M, Montes J, Glanzman AM, Bishop K, Zhong ZJ, Gheuens S, Bennett CF, Schneider E, Farwell W, Vivo DCD (2017) Nusinersen versus Sham Control in infantile-onset spinal muscular atrophy. N Engl J Med 377:1723–1732. https://doi.org/10.1056/NEJMoa1702752

Article  CAS  PubMed  Google Scholar 

French LS, Mellough CB, Chen FK, Carvalho LS (2020) A review of Gene, drug and cell-based therapies for Usher Syndrome. Front Cell Neurosci 14:183. https://doi.org/10.3389/fncel.2020.00183

Article  CAS  PubMed  PubMed Central  Google Scholar 

Garrison LP, Jackson T, Paul D, Kenston M (2019) Value-based pricing for emerging Gene therapies: the Economic Case for a higher cost-effectiveness threshold. J Manag Care Spec Pharm 25. https://doi.org/10.18553/jmcp.2019.18378

Géléoc GGS, El-Amraoui A (2020) Disease mechanisms and gene therapy for Usher syndrome. Hear Res 394:107932. https://doi.org/10.1016/j.heares.2020.107932

Article  PubMed  Google Scholar 

Ghadessi M, Di J, Wang C, Toyoizumi K, Shao N, Mei C, Demanuele C, Tang R, Sammi), McMillan G, Beckman RA (2023) Decentralized clinical trials and rare diseases: a Drug Information Association Innovative Design Scientific Working Group (DIA-IDSWG) perspective. Orphanet J Rare Dis 18:79. https://doi.org/10.1186/s13023-023-02693-7

Article  PubMed  PubMed Central  Google Scholar 

György B, Meijer EJ, Ivanchenko MV, Tenneson K, Emond F, Hanlon KS, Indzhykulian AA, Volak A, Karavitaki KD, Tamvakologos PI, Vezina M, Berezovskii VK, Born RT, O’Brien M, Lafond J-F, Arsenijevic Y, Kenna MA, Maguire CA, Corey DP (2019) Gene Transfer with AAV9-PHP.B rescues hearing in a mouse model of Usher Syndrome 3A and Transduces Hair Cells in a non-human primate. Mol Ther Methods Clin Dev 13:1–13. https://doi.org/10.1016/j.omtm.2018.11.003

Article  CAS  PubMed  Google Scholar 

Hartong DT, Berson EL, Dryja TP (2006) Retinitis pigmentosa. Lancet 368:1795–1809. https://doi.org/10.1016/S0140-6736(06)69740-7

Article  CAS  PubMed  Google Scholar 

Huang X, Chau Y (2019) Intravitreal nanoparticles for retinal delivery. Drug Discov Today 24:1510–1523. https://doi.org/10.1016/j.drudis.2019.05.005

Article  CAS  PubMed